GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Izotropic Corp (XCNQ:IZO) » Definitions » YoY EBITDA Growth

Izotropic (XCNQ:IZO) YoY EBITDA Growth : 89.19% (As of Jan. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Izotropic YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Izotropic's YoY EBITDA Growth for the quarter that ended in Jan. 2024 was 89.19%.

Izotropic's EBITDA per Share for the three months ended in Jan. 2024 was C$-0.00.


Izotropic YoY EBITDA Growth Historical Data

The historical data trend for Izotropic's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Izotropic YoY EBITDA Growth Chart

Izotropic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
YoY EBITDA Growth
Get a 7-Day Free Trial 45.16 -170.59 -206.52 -9.22 30.52

Izotropic Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -27.59 37.84 60.00 50.00 89.19

Izotropic YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Izotropic's YoY EBITDA Growth for the fiscal year that ended in Apr. 2023 is calculated as:

YoY EBITDA Growth (A: Apr. 2023 )
=(EBITDA per Share (A: Apr. 2023 )-EBITDA per Share (A: Apr. 2022 ))/ | EBITDA per Share (A: Apr. 2022 ) |
=(-0.107--0.154)/ | -0.154 |
=30.52 %

Izotropic's YoY EBITDA Growth for the quarter that ended in Jan. 2024 is calculated as:

YoY EBITDA Growth (Q: Jan. 2024 )
=(EBITDA per Share (Q: Jan. 2024 )-EBITDA per Share (Q: Jan. 2023 )) / | EBITDA per Share (Q: Jan. 2023 )) |
=(-0.004--0.037)/ | -0.037 |
=89.19 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Izotropic YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Izotropic's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Izotropic (XCNQ:IZO) Business Description

Traded in Other Exchanges
Address
800 - 15355, 24th Avenue, Suite 424, Surrey, BC, CAN, V4A 2H9
Izotropic Corp is a research and development company specializing in cancer research and early detection for breast cancer. The Izotropic Breast CT Imaging System, IZOview produces high-resolution breast images in 3D. The company has a worldwide license from the University of California to commercialize the technology.

Izotropic (XCNQ:IZO) Headlines

No Headlines